NPI: 1487749495 · SAN BERNARDINO, CA 92408 · Obstetrics & Gynecology Physician · NPI assigned 10/04/2006
Authorized official FELDKAMP IV, IRVING controls 20+ related entities in our dataset. Read more
| Authorized Official | FELDKAMP IV, IRVING (OWNER) |
| NPI Enumeration Date | 10/04/2006 |
Other providers sharing the same authorized official: FELDKAMP IV, IRVING
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 22,784 | $2.87M |
| 2019 | 32,025 | $2.68M |
| 2020 | 32,471 | $2.40M |
| 2021 | 36,675 | $2.56M |
| 2022 | 34,713 | $2.17M |
| 2023 | 42,435 | $2.55M |
| 2024 | 39,572 | $2.01M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | 3,268 | 3,077 | $3.17M |
| S0199 | Medically induced abortion by oral ingestion of medication including all associated services and supplies (e.g., patient counseling, office visits, confirmation of pregnancy by hcg, ultrasound to confirm duration of pregnancy, ultrasound to confirm completion of abortion) except drugs | 4,640 | 4,569 | $2.34M |
| J7298 | Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg | 1,559 | 1,419 | $1.44M |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 21,940 | 20,530 | $1.15M |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 22,791 | 22,582 | $731K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 22,745 | 22,538 | $727K |
| 58300 | 7,330 | 3,664 | $672K | |
| J7296 | Levonorgestrel-releasing intrauterine contraceptive system, (kyleena), 19.5 mg | 634 | 634 | $638K |
| J3490 | Unclassified drugs | 17,799 | 16,244 | $621K |
| 11981 | 2,609 | 2,553 | $554K | |
| 59840 | 2,909 | 1,580 | $524K | |
| S4993 | Contraceptive pills for birth control | 3,211 | 3,203 | $510K |
| 90651 | 1,530 | 1,525 | $411K | |
| A4267 | Contraceptive supply, condom, male, each | 24,818 | 24,695 | $370K |
| S0190 | Mifepristone, oral, 200 mg | 5,036 | 5,006 | $323K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 5,880 | 5,793 | $317K |
| J7300 | Intrauterine copper contraceptive (paragard) | 323 | 285 | $262K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 3,393 | 3,384 | $255K |
| 87806 | 8,752 | 8,733 | $238K | |
| J7304 | Contraceptive supply, hormone containing patch, each | 96 | 95 | $233K |
| 11976 | 3,813 | 1,936 | $211K | |
| J7301 | Levonorgestrel-releasing intrauterine contraceptive system (skyla), 13.5 mg | 286 | 166 | $211K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 2,427 | 2,352 | $200K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 5,905 | 5,851 | $194K |
| 87799 | 3,546 | 3,526 | $144K | |
| 58301 | 4,530 | 2,286 | $130K | |
| 87481 | 3,559 | 3,539 | $119K | |
| 01966 | 1,147 | 1,134 | $79K | |
| 81025 | 22,336 | 21,485 | $67K | |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 408 | 407 | $59K |
| 87563 | 1,338 | 1,333 | $51K | |
| Q0144 | Azithromycin dihydrate, oral, capsules/powder, 1 gram | 5,171 | 4,894 | $43K |
| 99201 | 700 | 699 | $34K | |
| 99000 | 2,905 | 2,892 | $33K | |
| G9920 | Screening performed and negative | 4,645 | 4,622 | $32K |
| 76830 | Ultrasound, transvaginal | 393 | 391 | $27K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 812 | 785 | $22K |
| S0191 | Misoprostol, oral, 200 mcg | 5,036 | 5,007 | $16K |
| 11982 | 205 | 117 | $14K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 158 | 158 | $12K |
| 57454 | 196 | 99 | $11K | |
| S9445 | Patient education, not otherwise classified, non-physician provider, individual, per session | 853 | 853 | $11K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 81 | 81 | $8K |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | 380 | 371 | $5K |
| 81002 | 1,742 | 1,709 | $4K | |
| 85018 | 1,792 | 1,765 | $4K | |
| T1014 | Telehealth transmission, per minute, professional services bill separately | 1,802 | 1,736 | $4K |
| 83986 | 1,034 | 994 | $3K | |
| Q0111 | Wet mounts, including preparations of vaginal, cervical or skin specimens | 799 | 795 | $3K |
| 87210 | 554 | 542 | $2K | |
| 76998 | 15 | 15 | $2K | |
| 86901 | 626 | 623 | $2K | |
| 99152 | 26 | 26 | $1K | |
| G9919 | Screening performed and positive and provision of recommendations | 161 | 161 | $258.97 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 31 | 31 | $18.13 |